HF
SNOA icon

HRT Financial’s Sonoma Pharmaceuticals SNOA Stock Holding History

HRT Financial’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,843
Closed -$25K – 3453
2025
Q1 		$25K Buy
+11,843
New +$32K ﹤0.01% 2286
2024
Q3 		– Sell
-1,076
Closed -$4K – 3078
2024
Q2 		$4K Buy
+1,076
New +$3.83K ﹤0.01% 2054
2024
Q1 		– Sell
-1,393
Closed -$5K – 3038
2023
Q4 		$5K Buy
+1,393
New +$8.88K ﹤0.01% 2132

Other funds holding SNOA

HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.08B AUM 7.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's SNOA Position: Q2 2025 in Review

HRT Financial sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2025, closing a stake of 11,843 shares — an estimated $25K sold.

HRT Financial first reported a position in SNOA in Q4 2023 and held it in 3 quarters. The position peaked at $25K in Q1 2025. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2025.

  • HRT Financial reported no remaining Sonoma Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 11,843 Sonoma Pharmaceuticals shares in Q2 2025, an estimated $25K.
  • HRT Financial first reported a position in Sonoma Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • HRT Financial's Sonoma Pharmaceuticals position peaked at $25K in Q1 2025.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.